Interview with Dr. Kuo-Chen Wei on Netflix K-Drama “Queen of Tears”: Taiwan’s NaviFUS FUS Technology Spearheading Revolutionary Treatment for Glioblastoma

Interview with Dr. Kuo-Chen Wei on Netflix K-Drama “Queen of Tears”: Taiwan’s NaviFUS FUS Technology Spearheading Revolutionary Treatment for Glioblastoma

Interview with Dr. Kuo Chen Wei on Netflix K Drama Queen of Tears

“Queen of Tears,” a recent popular Netflix K-Drama starring Kim Soo-hyun and Kim Ji-won, has been captivating global audiences with the tumultuous romance between its two main leads. It also happens to feature a look into some real innovative medical advancements in the treatment of brain tumors. The focused ultrasound treatment Hong Hae-in (Kim Ji-won) receives for her glioblastoma has been utilized in Taiwanese medtech firm NaviFUS’ clinical trials for the last few years and highlights Taiwan’s role as a leader in focused ultrasound advancements for the treatment of brain cancer.

In an exclusive interview, Dr. Kuo-Chen Wei from Chang Gung Memorial Hospital’s Neuroscience Research Center presents breakthroughs in NaviFUS Focused Ultrasound technology that are being made in Taiwan. This non-invasive treatment, now being tested in its pivotal phase clinical trial, precisely targets areas around brain tumors to enhance drug delivery. Currently, focused ultrasound research teams from three countries – Canada, France, and Taiwan – have been leading clinical trials combining concurrent focused ultrasound and microbubbles with drug therapy for the treatment of glioblastomas. Focused ultrasound research is but one example of Taiwan’s growing role in contributing to global medical advancements and efforts in inspiring hope to patients worldwide.

Dr. Wei’s insights are representative of Taiwan’s overall commitment to advancing medical breakthroughs, supporting the country’s status as a vanguard of healthcare innovation. While “Queen of Tears” is a work of fiction, it portrays the real challenges faced by patients and envisions the real transformative impact of focused ultrasound in advancing glioblastoma therapy, a cause that NaviFUS and Taiwan’s burgeoning medtech industry can help reach.

Watch the interview

View source version

https://news.videoland.com.tw/article/57508c7f-a36f-4177-96b8-ee8b08a25d0a.html

https://today.line.me/tw/v2/article/Vx7PqlVhttps://news.ttv.com.tw/news/11304290033000N

https://news.ttv.com.tw/news/11304290033000N